General
Preferred name
FONDAPARINUX
Synonyms
Natural heparin pentasaccharide Sodium ()
Fondaparin sodium ()
SR-90107A ()
Arixtra ()
FONDAPARINUX SODIUM ()
Fondaparinux (sodium) ()
Fondaparinux Sodium (Org 31540) ()
Natural heparin pentasaccharide Sodium, Fondaparin sodium, SR-90107A ()
ORG-31540 FREE ACID ()
ORG31540 FREE ACID ()
SR 901107A ()
SR-901107A ()
Fondaparinux sodico ()
SR-90107A DECASODIUM SALT ()
Fondaparinux sodium for assay ()
IC-851589 ()
Quixidar ()
Fondaparinux sodique ()
SR 90107A ()
ORG-31540 ()
ORG 31540 ()
Fondaparinux sodium identification ()
SR 90107A DECASODIUM SALT ()
Fondaparinux (sodium salt) ()
P&D ID
PD051070
CAS
104993-28-4
114870-03-0
Tags
available
drug
Approved by
FDA
First approval
2001
Drug indication
Atrial fibrillation
Venous thrombosis
Venous thromboembolism
Drug Status
approved
investigational
withdrawn
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Synthetic pentasaccharide Factor Xa inhibitor (via ATIII binding). The ChEMBL and PubChem links given here are without the sodium ions contained in the INN structure of this compound. Database entries include the sodium salt (e.g. PubChem CID 636380). (GtoPdb)
DESCRIPTION Fondaparinux sodium (SR-90107A) is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity. (TargetMol Bioactive Compound Library)
Compound Sets
24
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
External IDs
118
Properties
(calculated by RDKit )
Molecular Weight
1506.95
Hydrogen Bond Acceptors
39
Hydrogen Bond Donors
19
Rotatable Bonds
30
Ring Count
5
Aromatic Ring Count
0
cLogP
-13.75
TPSA
805.48
Fraction CSP3
0.94
Chiral centers
25.0
Largest ring
6.0
QED
0.03
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Factor Xa
F10, SERPINC1
Indication
deep vein thrombosis (DVT)
MOA
coagulation factor inhibitor
ATC
B01AX05
Biosynthetic Origin
Carbohydrate (Aminoglycoside)
Therapeutic Indication
Anticoagulant
Therapeutic Class
Cardiovascular
Anticoagulants
Pathway
Metabolic Enzyme/Protease
Metabolism
Source data